
Keywords: A1PI; Virus; Prions; Safety; Purity; Stability; ADA; anti-drug antibody; A1PI; alpha1-proteinase inhibitor; B19V; parvovirus B19; BVDV; bovine viral diarrhea virus; CJD; Creutzfeldt-Jakob-Disease; CPV; canine parvovirus; DTT; dithiothreitol; EMA; European